Our data support the hypothesis that 68Ga-PSMA-617 PET/CT can more accurately differentiate primary PCa with PSA levels of 4–20 ng/ml than mpMRI, and that 68Ga-PSMA-617 uptake is positively correlated with the clinical risk parameters GS and PSA level. The gene discussed is FOLH1; the disease is posterior cortical atrophy.